These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 15170890)
1. Retinoic acid therapy in "degenerative-like" neuro-langerhans cell histiocytosis: a prospective pilot study. Idbaih A; Donadieu J; Barthez MA; Geissmann F; Bertrand Y; Hermine O; Brugières L; Genereau T; Thomas C; Hoang-Xuan K Pediatr Blood Cancer; 2004 Jul; 43(1):55-8. PubMed ID: 15170890 [TBL] [Abstract][Full Text] [Related]
2. Treatment of neurodegenerative CNS disease in Langerhans cell histiocytosis with a combination of intravenous immunoglobulin and chemotherapy. Imashuku S; Okazaki N'; Nakayama M; Fujita N; Fukuyama T; Koike K; Minato T; Kobayashi R; Morimoto A; Pediatr Blood Cancer; 2008 Feb; 50(2):308-11. PubMed ID: 17458874 [TBL] [Abstract][Full Text] [Related]
3. Analysis of outcome for patients with mass lesions of the central nervous system due to Langerhans cell histiocytosis treated with 2-chlorodeoxyadenosine. Dhall G; Finlay JL; Dunkel IJ; Ettinger LJ; Kellie SJ; Allen JC; Egeler RM; Arceci RJ Pediatr Blood Cancer; 2008 Jan; 50(1):72-9. PubMed ID: 17455311 [TBL] [Abstract][Full Text] [Related]
4. [Adult onset Langerhans cell histiocytosis with progressive cerebellar ataxia and spastic paraparesis]. Kobessho H; Fukunaga A; Mitsui S; Sekiguchi K; Oishi K; Ishihara H; Kanda F Rinsho Shinkeigaku; 2006 Oct; 46(10):725-8. PubMed ID: 17323785 [TBL] [Abstract][Full Text] [Related]
5. Improved outcome in the treatment of pediatric multifocal Langerhans cell histiocytosis: Results from the Japan Langerhans Cell Histiocytosis Study Group-96 protocol study. Morimoto A; Ikushima S; Kinugawa N; Ishii E; Kohdera U; Sako M; Fujimoto J; Bessho F; Horibe K; Tsunematsu Y; Imashuku S; Cancer; 2006 Aug; 107(3):613-9. PubMed ID: 16804933 [TBL] [Abstract][Full Text] [Related]
6. A phase II trial using thalidomide for Langerhans cell histiocytosis. McClain KL; Kozinetz CA Pediatr Blood Cancer; 2007 Jan; 48(1):44-9. PubMed ID: 16333818 [TBL] [Abstract][Full Text] [Related]
7. Permanent consequences in Langerhans cell histiocytosis patients: a pilot study from the Histiocyte Society-Late Effects Study Group. Haupt R; Nanduri V; Calevo MG; Bernstrand C; Braier JL; Broadbent V; Rey G; McClain KL; Janka-Schaub G; Egeler RM Pediatr Blood Cancer; 2004 May; 42(5):438-44. PubMed ID: 15049016 [TBL] [Abstract][Full Text] [Related]
8. A pilot study of priming with granulocyte macrophage colony-stimulating factor plus all-trans retinoic acid combined with remission induction chemotherapy in patients with acute myeloid leukemia. Shin HJ; Chung JS; Choi YJ; Cho GJ Am J Clin Oncol; 2009 Jun; 32(3):227-32. PubMed ID: 19433969 [TBL] [Abstract][Full Text] [Related]
10. Fifteen years of treatment with intravenous immunoglobulin in central nervous system Langerhans cell histiocytosis. Gavhed D; Laurencikas E; Akefeldt SO; Henter JI Acta Paediatr; 2011 Jul; 100(7):e36-9. PubMed ID: 21166862 [TBL] [Abstract][Full Text] [Related]
11. Skeletal Langerhans cell histiocytosis in children: permanent consequences and health-related quality of life in long-term survivors. Lau LM; Stuurman K; Weitzman S Pediatr Blood Cancer; 2008 Mar; 50(3):607-12. PubMed ID: 17973322 [TBL] [Abstract][Full Text] [Related]
12. Multi-centre pilot study of 2-chlorodeoxyadenosine and cytosine arabinoside combined chemotherapy in refractory Langerhans cell histiocytosis with haematological dysfunction. Bernard F; Thomas C; Bertrand Y; Munzer M; Landman Parker J; Ouache M; Colin VM; Perel Y; Chastagner P; Vermylen C; Donadieu J Eur J Cancer; 2005 Nov; 41(17):2682-9. PubMed ID: 16291085 [TBL] [Abstract][Full Text] [Related]
13. Crusted Norwegian scabies in an adult with Langerhans cell histiocytosis: mishaps leading to systemic chemotherapy. Kartono F; Lee EW; Lanum D; Pham L; Maibach HI Arch Dermatol; 2007 May; 143(5):626-8. PubMed ID: 17515513 [TBL] [Abstract][Full Text] [Related]